טוען...
Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid
BACKGROUND: Zoledronic acid is used to treat bone metastases and has been shown to reduce skeletal-related events and exert antitumor activity. The present in vitro study investigates the mechanism of action of Zoledronic Acid on breast cancer cell lines with different hormonal and HER2 patterns. Fu...
שמור ב:
Main Authors: | , , , , , , , , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
BioMed Central
2012
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3519531/ https://ncbi.nlm.nih.gov/pubmed/23173568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2867-12-48 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|